Therapy resistance/chronicity, their determinants and potential solutions Hans-Jürgen Möller Editorial Open access 13 February 2020 Pages: 1 - 2
Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study Arnaud PanesAntoine ParienteAnnie Fourrier-Réglat Original Paper 11 December 2018 Pages: 3 - 10
Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study Parita ShahYusuke IwataAriel Graff-Guerrero Original Paper 19 August 2019 Pages: 11 - 22
Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993–2015 Michael SchneiderJohannes RegenteMartin Heinze Original Paper 30 November 2018 Pages: 23 - 33
Severe parkinsonism under treatment with antipsychotic drugs Katrin DruschkyStefan BleichSusanne Stübner Original Paper 23 August 2019 Pages: 35 - 47
Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients Priyanthi B. GjerdeCarmen E. SimonsenIngrid Melle Original Paper Open access 27 April 2019 Pages: 49 - 58
Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis Liisa LeppikMadis ParkseppMihkel Zilmer Original Paper 02 January 2019 Pages: 59 - 70
Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure Ádám KissÁdám MenusKatalin Monostory Original Paper 02 January 2019 Pages: 71 - 82
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design Christian Schmidt-KraepelinSandra FeyerabendJoachim Cordes Original Paper 05 September 2019 Pages: 83 - 94
Mental health in refugees and asylum seekers (MEHIRA): study design and methodology of a prospective multicentre randomized controlled trail investigating the effects of a stepped and collaborative care model Kerem BögeCarine KarnoukMalek Bajbouj Original paper 22 February 2019 Pages: 95 - 106
Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016 Timo GreinerBeatrice HaackMichael Schneider Original Paper 22 August 2019 Pages: 107 - 117
Inhibition of monoamine oxidase activity by repetitive transcranial magnetic stimulation: implications for inter-train interval and frequency Michael KaczmarczykFrancesca RegenJulian Hellmann-Regen Original Paper 17 December 2018 Pages: 119 - 126
A proteomic signature associated to atypical antipsychotic response in schizophrenia patients: a pilot study Daniel Martins-de-SouzaPaul C. GuestJohann Steiner Short Communication 01 April 2019 Pages: 127 - 134
Cannabidiol: a hope to treat non-motor symptoms of Parkinson's disease patients Sidra SaleemArsalan Anwar Letter to the Editor 05 June 2019 Pages: 135 - 135